Anemia with respect to iron, folic acid and vitamin b12. biochemistry oriented approach. preferably clinical implications.

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Searching PubMed

"iron deficiency anemia" OR "megaloblastic anemia" biochemistry mechanisms

I now have comprehensive information from multiple textbooks. Let me compile the full answer:

Anemia: Iron, Folic Acid & Vitamin B12 - A Biochemistry-Oriented Approach

PART 1: IRON DEFICIENCY ANEMIA

Normal Iron Biochemistry (the foundation)

Total body iron is ~2.5 g in women and ~3.5 g in men (up to 6 g in some males). It is distributed across three functional pools:

Pool	Male (mg)	Female (mg)
Hemoglobin	2100	1750
Myoglobin	300	250
Enzymes (catalase, cytochromes)	50	50
Storage (ferritin + hemosiderin)	1000	400

Daily dietary iron: 10-20 mg. Losses: 1-2 mg/day through mucosal/skin epithelial cell shedding. There is no regulated excretion pathway - balance is entirely governed by absorption.

Absorption Biochemistry

Dietary heme iron (from meat): ~20% absorbable
Non-heme iron (vegetables): only ~1-2% absorbable
In the duodenum: duodenal cytochrome B (a ferric reductase) reduces Fe³⁺ → Fe²⁺
Fe²⁺ crosses the apical membrane via DMT-1 (divalent metal transporter-1)
Ferroportin moves iron across the basolateral membrane into plasma
Hephaestin and ceruloplasmin re-oxidize Fe²⁺ → Fe³⁺ for binding to transferrin

The Hepcidin Regulatory Axis

Hepcidin (a small peptide from the liver) is the master regulator of systemic iron:

It binds ferroportin → causes its internalization and degradation
This blocks iron export from duodenal enterocytes, macrophages, and hepatocytes
HFE protein on hepatocyte surfaces senses plasma iron levels and adjusts hepcidin accordingly
High iron → high hepcidin → less ferroportin → less iron absorbed
Low iron / increased erythropoiesis → erythroblasts secrete erythroferrone → suppresses hepcidin → more iron absorbed
Inflammation (IL-6) → raises hepcidin → iron sequestration (basis of anemia of chronic disease)

Storage Forms

Ferritin: protein-iron complex, highest in hepatocytes and splenic/marrow macrophages. Serum ferritin reflects body stores. In iron deficiency: serum ferritin <12 μg/L
Hemosiderin: aggregated ferritin from lysosomal degradation; chemically reactive, stains positive with Prussian blue (potassium ferrocyanide)

Transferrin

Synthesized in liver; normally ~33% saturated with iron
Serum iron: ~120 μg/dL in men, ~100 μg/dL in women
Total iron-binding capacity (TIBC): 300-350 μg/dL

Pathogenesis of Iron Deficiency Anemia

Causes differ by population:

Low-resource countries: inadequate dietary intake + parasitic blood loss (hookworm)
Women of childbearing age: menstrual blood loss + pregnancy demands
Toddlers: rapid growth outpacing intake
Elderly/post-gastrectomy: achlorhydria impairs iron release from food
Occult GI bleeding: always suspect in adults, especially males or post-menopausal women

As stores deplete, the sequence is: Storage iron depleted → serum ferritin falls → serum iron falls, TIBC rises → transferrin saturation <15% → hepcidin levels fall → finally, hemoglobin synthesis is impaired.

Lab Findings

Parameter	Iron Deficiency	Anemia of Chronic Disease
Serum iron	Low	Low
TIBC	High	Low/normal
Ferritin	Low (<12 μg/L)	High
Transferrin saturation	<15%	Low/normal
Marrow storage iron	Absent	Increased
Hepcidin	Low	High

Blood film: microcytic, hypochromic RBCs with poikilocytosis (pencil cells/elliptocytes characteristic)

Clinical Implications

Respond to oral iron in 5-7 days (reticulocytosis) → normalizes counts over weeks
Anemia of chronic disease mimics but requires treating the underlying condition; some benefit from erythropoietin
IV iron indicated when oral iron fails (malabsorption, IBD) or rapid correction needed
Screen: serum ferritin (first to fall), then transferrin saturation

PART 2: FOLATE (FOLIC ACID) DEFICIENCY ANEMIA

Biochemical Role of Folate in DNA Synthesis

Folate operates as a one-carbon carrier in the form of tetrahydrofolate (THF) and its derivatives:

The key reaction causing anemia is:

dUMP + N5,N10-methylene-THF  →  dTMP + DHF
        (via Thymidylate Synthase)

N5,N10-methylene-THF donates a methyl group to convert dUMP → dTMP (deoxythymidine monophosphate)
dTMP is the immediate precursor of dTTP, which is required for DNA synthesis
In folate deficiency: 5,10-methylene-THF is markedly reduced → thymidylate synthase is starved → dTTP cannot be made → DNA synthesis blocked
The consequence: cells continue to grow (RNA/protein synthesis unaffected) but cannot divide → nuclear-cytoplasmic asynchrony = megaloblastic morphology

The cells most affected are those with the highest division rates: erythroid precursors and GI epithelium.

Causes of Folate Deficiency

Inadequate intake: alcoholism, poverty, elderly (most common cause)
Increased demand: pregnancy, hemolytic anemia, rapid growth
Drugs: methotrexate (inhibits DHFR), trimethoprim, phenytoin, sulfasalazine
Malabsorption: celiac disease

Unlike B12, body stores of folate last only weeks to months (not years), so deficiency develops rapidly with poor intake.

Folate-Homocysteine-B12 Interconnection

The methionine cycle connects folate and B12 biochemically:

Homocysteine  →  Methionine
   ↑
N5-methyl-THF donates methyl group
   ↑
requires Methionine Synthase (B12-dependent)

N5-methyl-THF is the circulating form of folate in plasma
To be recycled back to THF (for use in other reactions), it must donate its methyl group to homocysteine → methionine
This reaction requires vitamin B12 (methylcobalamin) as the cofactor
If B12 is deficient: folate is "trapped" as N5-methyl-THF = "methyl-folate trap"
Result: functional folate deficiency even if dietary folate is adequate

Clinical implication: In B12 deficiency, giving folate supplements temporarily corrects the anemia (by bypassing the methyl-trap) but does NOT prevent and may actually accelerate the neurological damage - a critical clinical pitfall.

Hyperhomocysteinemia as a Clinical Consequence

Both folate AND B12 deficiency lead to elevated homocysteine because the re-methylation of homocysteine to methionine fails. Elevated homocysteine is an independent risk factor for:

Atherosclerosis
Arterial and venous thrombosis
Hypertension
Neural tube defects (when folate-deficient in early pregnancy)

Folate supplementation 400 μg/day before conception significantly reduces the risk of spina bifida and anencephaly - the basis for mandatory flour fortification in many countries.

Lab Findings

Macrocytic (MCV >100 fL), megaloblastic anemia
Hypersegmented neutrophils (>5 lobes in >5% of neutrophils, or any with ≥6 lobes)
Low serum folate and low RBC folate (RBC folate better reflects tissue stores)
Elevated homocysteine (elevated in both folate and B12 deficiency)
Normal methylmalonic acid (MMA is elevated only in B12 deficiency - key distinguishing test)
Macro-ovalocytes, anisocytosis, poikilocytosis on blood film

PART 3: VITAMIN B12 (COBALAMIN) DEFICIENCY ANEMIA

B12 Absorption - A Multi-Step Process

B12 absorption is uniquely complex, making it vulnerable at many points:

Stomach: Pepsin releases B12 from food proteins; B12 binds haptocorrin (R-protein, from saliva)
Duodenum: Pancreatic proteases release B12 from haptocorrin; B12 binds Intrinsic Factor (IF) - secreted by gastric parietal cells
Ileum: IF-B12 complex binds cubilin receptor on ileal enterocytes → endocytosed
Plasma: B12 is released from ileal cells bound to transcobalamin II → delivered to liver and rapidly dividing cells (bone marrow, GI epithelium)

Body stores: 5-20 years worth, held mainly in the liver. This is why deficiency takes years to manifest even after absorption stops.

Causes

Cause	Mechanism
Pernicious anemia (most common in Western countries)	Autoimmune destruction of parietal cells → no IF; anti-IF antibodies and anti-parietal cell antibodies
Gastrectomy / gastric bypass	Loss of IF-secreting parietal cells
Ileal resection / Crohn disease / celiac	Loss of cubilin-expressing ileal absorptive cells
Achlorhydria (elderly, H. pylori, PPIs)	Cannot release food-bound B12 from protein
Veganism (strict)	No dietary source (B12 only in animal products)
Pancreatic insufficiency	Cannot cleave B12 from haptocorrin
Fish tapeworm (Diphyllobothrium)	Competitive consumption of B12 in intestine

Two Biochemical Roles of B12 - Both Causing Disease

Role 1: Methionine Synthase Cofactor (Methylcobalamin)

Methylcobalamin donates the methyl group from N5-methyl-THF to homocysteine → methionine
Deficiency → methyl-folate trap → megaloblastic anemia (same mechanism as folate deficiency)
Deficiency → elevated homocysteine

Role 2: Methylmalonyl-CoA Mutase Cofactor (Adenosylcobalamin)

Adenosylcobalamin is required for the conversion of methylmalonyl-CoA → succinyl-CoA
This reaction is important in the metabolism of odd-chain fatty acids and certain amino acids (Val, Ile, Thr, Met)
B12 deficiency → methylmalonyl-CoA and propionyl-CoA accumulate → elevated methylmalonic acid (MMA) in serum and urine
Accumulated methylmalonyl-CoA may be incorporated into myelin as abnormal fatty acids → disrupted myelin structure

This is the biochemical basis of subacute combined degeneration (SCD) - demyelination of:

Dorsal columns (posterior): loss of vibration sense, proprioception, Romberg positive
Lateral columns (corticospinal): spastic weakness, upper motor neuron signs
Peripheral nerves: symmetric numbness, tingling, burning (feet before hands)

Critical clinical point: Neurological damage can occur with a normal or near-normal MCV, and can precede anemia. Folate supplementation corrects the anemia but allows the neurological damage to progress undetected.

Lab Findings - B12 vs Folate Differentiation

Parameter	B12 Deficiency	Folate Deficiency
Serum B12	Low	Normal
Serum folate	Normal or high	Low
RBC folate	Low (methyl-trap)	Low
Homocysteine	Elevated	Elevated
Methylmalonic acid (MMA)	Elevated	Normal
Anti-IF antibodies	Positive (pernicious)	Negative
Neurological features	Yes (SCD)	No

MMA is the key test to distinguish B12 from folate deficiency when both homocysteine and megaloblastic anemia are present.

Clinical Features

Pallor, fatigue, dyspnea (from anemia)
Mild jaundice (ineffective erythropoiesis with intramedullary hemolysis)
Beefy red, smooth tongue (glossitis - from megaloblastic changes in oropharyngeal epithelium)
Neurological: numbness/tingling → unsteady gait → loss of proprioception/vibration → spastic paraparesis
Reticulocyte rise within 2-3 days of B12 treatment (dramatic, diagnostically useful)
Pernicious anemia carries increased risk for gastric carcinoma - surveillance endoscopy every 3 years recommended

Bone Marrow: The Unifying Picture in Megaloblastic Anemia

The hallmark is nuclear-cytoplasmic asynchrony:

Nucleus: retarded maturation, "open" (delicate) chromatin
Cytoplasm: normal or even excessive (RNA/protein synthesis continues)
Giant metamyelocytes, hypersegmented neutrophils
Pancytopenia (ineffective erythropoiesis + intramedullary destruction)
Marrow is hyperplastic despite peripheral pancytopenia - a paradox explained by premature destruction of abnormal megaloblasts before they mature

Summary Comparison Table

Feature	Iron Deficiency	Folate Deficiency	B12 Deficiency
MCV	Low (microcytic)	High (macrocytic)	High (macrocytic)
Blood film	Hypochromic, pencil cells	Macro-ovalocytes	Macro-ovalocytes
Neutrophils	Normal	Hypersegmented	Hypersegmented
Ferritin	Low	Normal	Normal
TIBC	High	Normal	Normal
Serum folate	Normal	Low	Normal/high
Serum B12	Normal	Normal	Low
Homocysteine	Normal	High	High
MMA	Normal	Normal	High
Neurological deficit	No	No	Yes (SCD)
Key biochemical block	Hemoglobin synthesis (heme/globin chain impaired)	dTTP synthesis (thymidylate synthase starved)	dTTP synthesis + myelin (methylmalonyl-CoA mutase)

Sources:

Robbins, Cotran & Kumar - Pathologic Basis of Disease
Robbins & Kumar - Basic Pathology
Harper's Illustrated Biochemistry, 32nd Ed
Basic Medical Biochemistry - A Clinical Approach, 6th Ed
Henry's Clinical Diagnosis and Management by Laboratory Methods
Yamada's Textbook of Gastroenterology, 7th Ed

Can you give me some clinical questions regarding this

Here are 15 clinical vignette-style questions covering the biochemistry of all three types of anemia. Answers and explanations follow each question.

Section A: Iron Deficiency Anemia

Q1. A 28-year-old woman presents with fatigue and pallor for 3 months. She has heavy menstrual periods. Labs: Hb 8.2 g/dL, MCV 68 fL, serum iron 45 μg/dL, TIBC 480 μg/dL, ferritin 6 μg/L. Blood film shows hypochromic microcytic RBCs with pencil cells.

Which of the following best explains why TIBC is elevated in this patient?

A. The liver is producing less transferrin due to chronic inflammation B. The liver upregulates transferrin production in response to low iron stores C. Hepcidin is activating ferroportin on enterocytes D. Erythroferrone is suppressing transferrin synthesis E. Transferrin saturation exceeds 50%, stimulating more production

Answer & Explanation

Answer: B

Transferrin is synthesized in the liver. When iron stores are low (signaled by falling ferritin and reduced HFE saturation), the liver upregulates transferrin synthesis - this is an adaptive response to scavenge more iron from the circulation. TIBC reflects total transferrin capacity. In iron deficiency: serum iron is low + TIBC is high + transferrin saturation falls below 15%.

Contrast with anemia of chronic disease: IL-6 suppresses liver protein synthesis → TIBC is low despite low serum iron - a key distinguishing feature.

Q2. A 55-year-old man is found to have iron deficiency anemia. He denies any GI symptoms. His ferritin is 8 μg/L, transferrin saturation 11%. He is started on oral iron. After 3 weeks he reports no improvement.

What is the most likely biochemical reason for treatment failure?

A. Hepcidin levels are too low to allow absorption B. DMT-1 on enterocytes is genetically absent C. Concurrent occult GI blood loss is outpacing absorption D. Ferroportin has been upregulated by high erythroferrone E. Ceruloplasmin deficiency prevents re-oxidation of iron to Fe³⁺

Answer & Explanation

Answer: C

In a middle-aged or older male with new iron deficiency anemia and no response to oral iron, the most important clinical concern is ongoing occult GI blood loss (colorectal cancer, peptic ulcer, angiodysplasia) that exceeds the rate at which oral iron can replace stores. This patient needs urgent colonoscopy and upper GI endoscopy.

The biochemistry: absorption is limited to ~1-2 mg/day in a healthy gut even with maximal hepcidin suppression. If blood loss exceeds this, supplementation cannot correct the deficit.

Q3. A patient with rheumatoid arthritis has Hb 9.5 g/dL, MCV 78 fL, serum iron 40 μg/dL, TIBC 200 μg/dL, ferritin 180 μg/L, and increased storage iron on bone marrow biopsy.

Which molecule is primarily responsible for the iron pattern seen in this patient?

A. Erythroferrone B. Transferrin C. Hepcidin D. DMT-1 E. Ferroportin

Answer & Explanation

Answer: C

This is anemia of chronic disease (ACD). IL-6 from chronic inflammation drives hepatic hepcidin production. Hepcidin binds ferroportin on macrophages and duodenal enterocytes → ferroportin is internalized and degraded → iron is trapped in macrophage stores (hence high ferritin, high marrow iron) and cannot be transferred to erythroid precursors. The result is functional iron deficiency despite iron overload.

Erythroferrone (secreted by erythroblasts) normally suppresses hepcidin during erythropoietic stress - but in ACD, the inflammatory signal overrides it.

Section B: Folate Deficiency Anemia

Q4. A 34-year-old chronic alcoholic presents with fatigue, glossitis, and diarrhea. Hb 7.8 g/dL, MCV 112 fL. Blood film: macro-ovalocytes, hypersegmented neutrophils. Serum folate is low. Serum B12 is normal. Serum homocysteine is elevated. Methylmalonic acid (MMA) is normal.

The megaloblastic changes in this patient are primarily due to impaired synthesis of which molecule?

A. Methionine B. S-adenosylmethionine (SAM) C. dTMP (deoxythymidine monophosphate) D. Succinyl-CoA E. Methylmalonyl-CoA

Answer & Explanation

Answer: C

The central biochemical lesion in folate deficiency is impaired thymidylate synthesis:

dUMP + N5,N10-methylene-THF → dTMP (via thymidylate synthase)

Without adequate 5,10-methylene-THF, dTMP cannot be made → dTTP pool is depleted → DNA synthesis is blocked → cells continue to grow (RNA/protein unaffected) but cannot divide → megaloblastic morphology.

Normal MMA rules out B12 deficiency. Elevated homocysteine occurs in both (due to failure to remethylate homocysteine via the methionine synthase reaction).

Q5. A 24-year-old woman in her first trimester of pregnancy is found to have macrocytic anemia. She took folic acid 400 μg/day starting only after her first missed period (4 weeks gestation).

For which complication would periconceptional folate have been most protective, and why?

A. Placental abruption, because folate reduces matrix metalloproteinase activity B. Neural tube defects, because folate is required for methylation reactions and DNA synthesis during neural tube closure at 3-4 weeks C. Gestational diabetes, because folate activates insulin signaling D. Pre-eclampsia, because folate reduces trophoblast invasion E. Fetal growth restriction, because folate enhances erythropoietin production

Answer & Explanation

Answer: B

Neural tube closure occurs at days 21-28 of gestation - before most women know they are pregnant. Folate is essential for DNA synthesis and methylation of CpG islands (epigenetic regulation) during this period of rapid neurulation. If folate is deficient, the rapidly dividing neuroepithelium cannot complete division → the tube fails to close.

This is why supplementation must begin before conception, not after a missed period. Taking folate at 4 weeks is already too late to prevent neural tube defects (closure is complete by then). Mandatory flour fortification exists precisely for this reason.

Q6. A medical student is studying the mechanism of methotrexate in cancer chemotherapy.

Which enzyme in the folate pathway does methotrexate inhibit, and what is the consequence for rapidly dividing cells?

A. Thymidylate synthase; blocks dTMP synthesis B. Dihydrofolate reductase (DHFR); prevents regeneration of THF, blocking DNA synthesis C. Methionine synthase; causes methyl-folate trap D. Methylenetetrahydrofolate reductase (MTHFR); reduces N5-methyl-THF availability E. Serine hydroxymethyltransferase; blocks one-carbon unit transfer

Answer & Explanation

Answer: B

Methotrexate is a DHFR inhibitor. After thymidylate synthase converts N5,10-methylene-THF to dTMP, the THF becomes DHF (dihydrofolate). DHFR normally reduces DHF back to THF (the active carrier form). Methotrexate tightly inhibits DHFR → DHF accumulates → THF pool is depleted → all folate-dependent one-carbon reactions are blocked → DNA synthesis halts in rapidly dividing cells.

Leucovorin (folinic acid) "rescues" normal cells by bypassing DHFR - it directly enters the folate cycle as formyl-THF, avoiding the methotrexate block. This is the basis of leucovorin rescue protocols.

Section C: Vitamin B12 Deficiency

Q7. A 65-year-old woman presents with progressive unsteadiness of gait and difficulty buttoning her shirt for 8 months, with only mild pallor. Neurological exam shows loss of vibration sense in her feet, positive Romberg sign, and mild spastic weakness. Hb is 10.2 g/dL, MCV 104 fL. Serum B12 is 98 pg/mL. Anti-intrinsic factor antibodies are positive. MMA is markedly elevated.

Why does this patient have neurological symptoms disproportionate to her degree of anemia?

A. The spinal cord is more sensitive to hypoxia than the bone marrow B. Adenosylcobalamin deficiency disrupts methylmalonyl-CoA metabolism, leading to incorporation of abnormal fatty acids into myelin C. Methylcobalamin deficiency causes demyelination by blocking homocysteine remethylation D. Anti-parietal cell antibodies directly cross-react with myelin basic protein E. Folate supplementation (taken unknowingly) corrected the anemia but allowed neuropathy to progress

Answer & Explanation

Answer: B (with E as an important additional consideration)

B12 has two biochemical roles using two different coenzyme forms:

Methylcobalamin - cofactor for methionine synthase → affects DNA synthesis → causes megaloblastic anemia
Adenosylcobalamin - cofactor for methylmalonyl-CoA mutase → converts methylmalonyl-CoA → succinyl-CoA

In B12 deficiency, methylmalonyl-CoA and propionyl-CoA accumulate. These abnormal substrates are incorporated into neuronal membrane phospholipids as branched-chain fatty acids → disrupted myelin architecture → subacute combined degeneration (SCD).

The neurological damage can precede or exceed the anemia. The severity of neuropathy does not correlate with the degree of anemia. E is also clinically important: if a patient with B12 deficiency is given folate supplements, the folate bypasses the methyl-trap and partially corrects the anemia - masking the diagnosis while neuropathy silently worsens.

Q8. A 70-year-old man on long-term omeprazole (PPI) for GERD has a serum B12 of 180 pg/mL (low), normal RBC size (MCV 88 fL), and mildly elevated MMA. He denies neurological symptoms.

Why can B12 deficiency in this patient present without macrocytic anemia?

A. PPIs directly stimulate erythropoiesis via iron absorption B. Neurological damage consumes B12, depleting less for the bone marrow C. The patient may have concurrent iron deficiency or thalassemia trait masking the macrocytosis D. B12 deficiency always presents with normal MCV in elderly patients E. DMT-1 is upregulated by PPIs, compensating for low B12

Answer & Explanation

Answer: C

This is a high-yield clinical pearl. MCV is a net result of competing processes. If a patient has B12 deficiency (tending to raise MCV) alongside:

Iron deficiency (tending to lower MCV)
Thalassemia trait (microcytic tendency)
Chronic disease

...the MCV may "cancel out" in the normal range, masking megaloblastic changes. The blood film may show a dimorphic population - a mix of macro-ovalocytes and microcytes. Always check B12 and folate when there is unexplained or mixed anemia, and use MMA and homocysteine to detect B12 deficiency even with a normal MCV.

PPIs reduce gastric acid → impaired release of food-bound cobalamin from dietary protein (not the same as pernicious anemia, where no IF is produced).

Q9. A strict vegan woman, 31 weeks pregnant, is found to have Hb 9.0 g/dL, MCV 118 fL, low B12, elevated homocysteine, and elevated MMA. Her doctor starts her on oral folic acid only, thinking it will treat her anemia.

What is the most dangerous consequence of this management?

A. Folic acid competes with B12 for absorption in the ileum B. The fetus will develop neural tube defects from folic acid excess C. Folic acid corrects the anemia but does not prevent B12 deficiency neuropathy, and may accelerate it D. Folic acid reduces hepcidin, worsening iron overload E. Excessive folic acid causes thrombocytopenia

Answer & Explanation

Answer: C

This is the most important clinical trap in this topic. Folate supplementation:

Bypasses the methyl-folate trap by providing free THF
Enough THF is produced to restore thymidylate synthesis → megaloblastic anemia improves
But the adenosylcobalamin-dependent methylmalonyl-CoA mutase pathway remains non-functional
Myelin continues to degrade → subacute combined degeneration progresses - now undetected because the anemia is "corrected"

This is why the diagnosis must always distinguish B12 from folate deficiency before starting treatment. In this vegan pregnant woman, parenteral B12 + folate is the correct treatment.

Section D: Integrative / Differentiation Questions

Q10. You receive the following labs for two patients presenting with macrocytic anemia and similar MCV values (~110 fL):

Lab	Patient A	Patient B
Serum B12	Normal	Low
Serum folate	Low	Normal/High
Homocysteine	Elevated	Elevated
MMA	Normal	Elevated
Neurological exam	Normal	Abnormal

Which patient has folate deficiency, and what single lab test most definitively distinguishes the two?

Answer & Explanation

Patient A = folate deficiency; Patient B = B12 deficiency

The single most useful distinguishing test is methylmalonic acid (MMA):

MMA is elevated only in B12 deficiency (because adenosylcobalamin is required for methylmalonyl-CoA mutase)
MMA is normal in pure folate deficiency
Both have elevated homocysteine (both methionine synthase pathways are disrupted in their respective deficiencies)

MMA is more specific and sensitive than serum B12 levels alone for diagnosing tissue B12 deficiency, especially in elderly patients where serum B12 may be borderline low.

Q11. A 45-year-old woman who had a Roux-en-Y gastric bypass 3 years ago presents with fatigue and peripheral neuropathy. Her labs show: Hb 9.5 g/dL, MCV 72 fL, low ferritin, low B12, normal folate. MMA is elevated.

What is the best explanation for her mixed picture?

A. She has two separate conditions: iron deficiency anemia AND B12 deficiency, both from the bypass B. Gastric bypass only causes B12 deficiency, and the microcytosis is from thalassemia C. B12 deficiency causes microcytosis when stores are severely depleted D. The elevated MMA is a false positive due to iron deficiency E. Folate deficiency is masking her true B12 level

Answer & Explanation

Answer: A

Gastric bypass causes multiple nutritional deficiencies due to:

Loss of parietal cells → no gastric acid + reduced IF → B12 malabsorption
Bypassed duodenum (primary site of iron absorption) → iron deficiency
Reduced food intake + altered gastric motility

The net MCV in this patient is low (microcytic, from iron deficiency dominating), despite coexisting B12 deficiency that would tend to raise it. This is the "masking" phenomenon again. She needs both parenteral B12 and iron supplementation (plus likely thiamine, zinc, and vitamin D). The neuropathy is from the B12 deficiency (elevated MMA confirms adenosylcobalamin-dependent pathway dysfunction).

Q12. A second-year medical student is asked why a patient with iron deficiency anemia does NOT develop hypersegmented neutrophils, while a patient with B12 deficiency does.

What is the best biochemical explanation?

A. Iron is required for neutrophil nuclear segmentation B. Hypersegmentation reflects impaired DNA synthesis in the granulocyte precursors, which only occurs in B12/folate deficiency C. Iron deficiency causes neutrophil apoptosis rather than abnormal segmentation D. The spleen removes hypersegmented neutrophils preferentially in iron deficiency E. IL-6 in iron deficiency suppresses granulopoiesis uniformly

Answer & Explanation

Answer: B

Hypersegmented neutrophils are a hallmark of megaloblastic processes (B12 or folate deficiency), not iron deficiency.

The mechanism: In B12/folate deficiency, DNA synthesis is impaired in all rapidly dividing cells - including myeloid precursors. Granulocyte precursors (metamyelocytes especially) undergo nuclear maturation arrest - the nucleus continues to develop lobes beyond the normal 3-5 because cells cannot divide normally. The result is giant metamyelocytes and hypersegmented neutrophils (>5 lobes in >5% of neutrophils, or any cell with ≥6 lobes).

In iron deficiency, DNA synthesis is unaffected - the problem is hemoglobin synthesis only (insufficient iron for heme production). Neutrophils develop normally.

Q13. A 58-year-old man with known pernicious anemia is on regular intramuscular vitamin B12 injections. He is also started on high-dose oral folic acid by his cardiologist for hyperhomocysteinemia.

Which of the following is a concern with adding folic acid in this patient, even though his B12 is being replaced?

A. Folic acid competes with B12 at the cubilin receptor B. High folic acid may convert B12 to an inactive form C. Folic acid may mask recurrence of B12 deficiency if injections are ever missed D. There is an increased risk of colorectal cancer in all patients on folic acid E. Folic acid reduces transcobalamin II, lowering effective B12 delivery

Answer & Explanation

Answer: C

This tests understanding of the "masking" problem in the real clinical setting. Even in a patient on B12 replacement, high-dose folic acid can mask B12 deficiency if the injections are discontinued or irregular - because folic acid will normalize the CBC (bypassing the methyl-trap) while subacute combined degeneration develops silently.

Additionally, as noted in Harper's Illustrated Biochemistry: high folic acid intake has a potential signal for increased transformation of premalignant colorectal polyps - so option D has some evidence but it applies to people with pre-existing polyps, not universally. The primary concern here remains the masking issue (C).

Q14. A newborn is diagnosed with methylmalonic acidemia due to a genetic defect in methylmalonyl-CoA mutase. The parents ask why this enzyme matters.

Which of the following best describes the metabolic consequence of this enzyme defect?

A. Homocysteine cannot be converted to methionine, causing demyelination B. Odd-chain fatty acids and certain amino acids cannot be fully oxidized, leading to toxic accumulation of methylmalonyl-CoA and propionate C. Folate cannot be regenerated to THF, causing megaloblastic anemia from birth D. Iron absorption is blocked at the duodenal enterocyte E. Thymidylate synthase is inhibited, preventing DNA replication

Answer & Explanation

Answer: B

Methylmalonyl-CoA mutase (adenosylcobalamin-dependent) converts methylmalonyl-CoA → succinyl-CoA, which enters the TCA cycle.

Sources of methylmalonyl-CoA:

Odd-chain fatty acid oxidation (propionyl-CoA → methylmalonyl-CoA)
Catabolism of branched-chain amino acids (Val, Ile) and certain amino acids (Thr, Met)

When this enzyme is deficient:

Methylmalonyl-CoA and propionate accumulate
Propionate is incorporated into fatty acid synthesis as a primer → odd-chain and branched-chain fatty acids are made → they disrupt membrane/myelin function
This is also the same pathway disrupted in acquired B12 deficiency causing subacute combined degeneration

This question bridges the genetic (inborn error) with the nutritional (B12 deficiency) etiology of the same pathway dysfunction.

Q15. A 19-year-old woman presents with fatigue and pallor. She has been a strict vegan for 2 years. Labs: Hb 9.8 g/dL, MCV 108 fL, B12 low at 140 pg/mL, folate normal, ferritin normal. Neurological exam is normal. MMA is elevated.

What is the most appropriate treatment?

A. Oral cyanocobalamin 1000 μg/day indefinitely B. Single IM hydroxocobalamin injection only C. High-dose oral folic acid to correct the anemia, with B12 deferred D. Dietary counseling alone, with a repeat CBC in 6 months E. IV iron with oral B12 supplementation

Answer & Explanation

Answer: A

In a strict vegan with B12 deficiency from inadequate intake (not malabsorption), oral high-dose B12 is effective because passive absorption (independent of intrinsic factor) occurs at ~1% of any oral dose - so 1000 μg/day provides ~10 μg absorbed, which meets the daily requirement of 2.4 μg.

This contrasts with pernicious anemia (where the intrinsic factor is absent), which requires intramuscular B12 (passive oral absorption can also work but is less reliable in pernicious anemia).

The elevated MMA confirms tissue-level B12 deficiency even before neurological symptoms appear - treatment is urgent. Folate alone (option C) is dangerous for the reasons discussed throughout this section. Dietary counseling alone is insufficient given already symptomatic deficiency. Single injection (B) is inadequate for sustained replacement in a vegan who will continue to have zero dietary intake.

These 15 questions cover the core biochemical mechanisms and their clinical applications. The recurring themes are:

Hepcidin-ferroportin axis as the master controller of iron balance
Thymidylate synthesis as the shared final common pathway for megaloblastic anemia
Methyl-folate trap as the link between B12 deficiency and functional folate deficiency
MMA elevation as the definitive marker distinguishing B12 from folate deficiency
The masking trap - folate correcting anemia while neuropathy progresses undetected

Can you give me a crisp table for the clinical parameters here with their normal ranges

Here is a crisp reference table of all clinical/lab parameters discussed, with normal ranges and their directional changes across all three anemias:

Lab Parameters in Iron, Folate & B12 Deficiency Anemia

Parameter	Normal Range	Iron Deficiency	Folate Deficiency	B12 Deficiency	Anemia of Chronic Disease
Hemoglobin (M/F)	13.5-17.5 / 12-16 g/dL	↓	↓	↓	↓ (mild)
MCV	80-100 fL	↓ (<80)	↑ (>100)	↑ (>100)	Normal or ↓
MCH	27-33 pg	↓	↑	↑	Normal or ↓
MCHC	32-36 g/dL	↓	Normal	Normal	Normal
Reticulocyte count	0.5-2.5%	↓	↓	↓	↓
Serum Iron	60-170 μg/dL	↓	Normal	Normal	↓
TIBC	250-370 μg/dL	↑	Normal	Normal	↓ or Normal
Transferrin Saturation	20-50%	↓ (<15%)	Normal	Normal	↓
Serum Ferritin	12-300 μg/L (M) / 12-150 μg/L (F)	↓↓ (<12)	Normal	Normal	↑
Serum Hepcidin	29-254 ng/mL	↓	Normal	Normal	↑↑
Serum B12	200-900 pg/mL	Normal	Normal	↓ (<200)	Normal
Serum Folate	3-20 ng/mL	Normal	↓ (<3)	Normal or ↑	Normal
RBC Folate	140-628 ng/mL	Normal	↓↓	↓ (methyl-trap)	Normal
Homocysteine	5-15 μmol/L	Normal	↑↑	↑↑	Normal
Methylmalonic Acid (MMA)	70-270 nmol/L	Normal	Normal	↑↑	Normal
Serum Haptocorrin (R-protein)	Present	Normal	Normal	Normal	Normal
Anti-Intrinsic Factor Ab	Negative	Negative	Negative	+ (pernicious)	Negative
Anti-Parietal Cell Ab	Negative	Negative	Negative	+ (pernicious, ~90%)	Negative
LDH	140-280 U/L	Normal	↑	↑	Normal
Indirect Bilirubin	0.1-1.0 mg/dL	Normal	↑ (mild)	↑ (mild)	Normal

Blood Film Findings

Feature	Iron Deficiency	Folate Deficiency	B12 Deficiency
RBC size	Microcytic	Macrocytic	Macrocytic
RBC color	Hypochromic	Normochromic	Normochromic
Characteristic cell	Pencil cells / elliptocytes	Macro-ovalocytes	Macro-ovalocytes
Neutrophils	Normal	Hypersegmented (>5 lobes)	Hypersegmented (>5 lobes)
Other	Anisocytosis, poikilocytosis	Anisocytosis, RBC fragments	Anisocytosis, RBC fragments

Bone Marrow

Feature	Iron Deficiency	Megaloblastic (B12 or Folate)
Cellularity	Normal or hyperplastic	Hyperplastic
Erythroid precursors	Normoblastic	Megaloblastic (large, open chromatin)
Iron stores (Prussian blue)	Absent	Normal or increased
Giant metamyelocytes	Absent	Present
Nuclear-cytoplasmic asynchrony	Absent	Present

Quick Decision Points

If you see this...	Think...
Low ferritin	Always iron deficiency (most specific single test)
High TIBC + low ferritin	Iron deficiency (not ACD)
High ferritin + low TIBC	Anemia of chronic disease
High MMA + high homocysteine	B12 deficiency
Normal MMA + high homocysteine	Folate deficiency
Low RBC folate despite normal serum folate	B12 deficiency (methyl-trap)
Neurological signs + macrocytic anemia	B12 deficiency until proven otherwise
Macrocytic anemia + normal MCV in same patient	Mixed deficiency (iron + B12/folate masking each other)

This is a shared conversation. Sign in to Orris to start your own chat.